EverQuote, Inc.: Raymond James raises target price to $32 from $28
EVER•Raymond James raised its target price for EverQuote to $32 from $28.
Related News
UBS cuts Pacific Biosciences of California target price to $2.70 from $3.05
PACB•
Peloton plans $200 million five-year revolving credit facility
PTON•
Odysight.ai plans to attend ROTH Technology and StoneX investor conferences
ODYS•
Bradbury Capital names Virginia Jaqveline Chan chief financial officer
BBCI•
Biodexa's Phase 3 eRapa trial for FAP reaches two-thirds enrollment
BDRX•